(¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Virtual) - 8¿ù 27ÀÏ (2ÀÏÂ÷) : 2021-08-27±³À°ÀÏÀÚ : 2021-08-27
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Virtual) - 8¿ù 27ÀÏ (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : À±ÁöÇö
¿¬¶ôó : 070-4895-6129
À̸ÞÀÏ :
bmt@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-27 CA C 09:00~09:30 Treosulfan Based Conditioning for Nonmalignant Diseases Lauri Burroughs(Fred Hutchinson Cancer Research Center)
±³À°½Ã°£ 08-27 CA C 09:30~10:00 HSCT and Gene Therapy for Primary Immunodeficiency Andrew Gennery(Newcastle University)
±³À°½Ã°£ 08-27 CA C 10:00~10:30 Optimizing the Conditioning Regimen of HSCT for Acquired Bone Marrow Failure in Children Nao Yoshida(Japanese Red Cross Nagoya First Hospital)
±³À°½Ã°£ 08-27 CA A 10:50~11:20 Ibrutinib and Other B Cell Directed Therapy in Chronic GVHD Corey Cuttler(Dana-Farber Cancer Institute)
±³À°½Ã°£ 08-27 CA A 11:20~11:50 Ruxolitinib for GVHD Management Robert Zeiser(University Medical Center Freiburg)
±³À°½Ã°£ 08-27 CA A 11:50~12:20 Intestinal Goblet Cell and IL-25 in Intestinal GVHD Takanori Teshima(Hokkaido University Graduate School of Medicine)
±³À°½Ã°£ 08-27 CA B 12:30~13:10 ±¹³» ITP guideline °³Á¤ ¹× ITP Ä¡·áÀÇ ÃֽŠÀü·«°ú Áö°ß Jun Ho Jan(Sungkyunkwan University School of Medicine)
±³À°½Ã°£ 08-27 CA A 13:20~14:20 Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma Tan-Huy Chu(Chonnam National University Hwasun hospital)
±³À°½Ã°£ 08-27 CA A 14:30~15:10 Perspectives, or future of CAR-T or immunotherapy David G Maloney(Fred Hutchinson Cancer Research Center)
±³À°½Ã°£ 08-27 CA A 15:20~15:50 CAR-NK Cells: A Promising Cellular Immunotherapy for Hematologic Malignancies Jianhua Yu(City of Hope National Medical Center)
±³À°½Ã°£ 08-27 CA A 15:50~16:20 Adoptive T-Cell Immunotherapy- Experiences in Preclinical and Clinical Studies Tai Gyu Kim(Catholic University of Korea)
±³À°½Ã°£ 08-27 CA B 16:20~16:50 Novel Immunotherapeutic Approaches with Antibody Drugs Hermann Einsele(University Hospital Würzburg)
±³À°½Ã°£ 08-27 CA A 17:00~18:00 Neonatal and Adult Megakaryocytopoiesis: Role of miRNA in Understanding Thrombocytopenia Ravi Kumar Gutti(University of Hyderabad)
±³À°½Ã°£ 08-27 CA A 18:10~18:50 A comparative Study of Incidences of Metabolic Diseases after Allogeneic Stem Cell Transplantation: a Korean Nationwide Case-Cohort Study Sung-Soo Park(The Catholic University of Korea)